AGREEMENT AND GENERAL RELEASEAgreement and General Release • May 10th, 2019 • Theravance Biopharma, Inc. • Pharmaceutical preparations • California
This Confidential Separation Agreement and General Release (“Agreement”) is made and entered into between Shehnaaz Suliman (“Employee”), for herself and her agents, heirs, executors, administrators, successors, and assigns (collectively referred to as “Releasors”), and Theravance Biopharma US, Inc. (“Theravance Biopharma” or “the Company”), and its predecessors, successors, assigns, related entities, its past, present and future parent companies, stockholders, sister companies, subsidiaries, divisions, officers, directors, partners, insurers, employees, agents and attorneys, past and present (collectively referred to as “Affiliates”). Theravance Biopharma and its Affiliates are collectively referred to herein as “Released Parties.” This Agreement may also refer to any of the Releasors or Released Parties as a “Party” or collectively as “the Parties.”
